Additionally, the co-localisation of TRPM7 with phosphatidylcholine-4,5-bisphosphate (PIP2) following antagonism treatment appeared to be greater in healthy participants than in those with ME/CFS [29]. Here, TRPM7 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.